Matches in Nanopublications for { ?s ?p "[Coactivators SRC-1, TIF-2, RAC3, p300, CBP, Tip60, and gelsolin are highly expressed in endocrine therapy-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Coactivators SRC-1, TIF-2, RAC3, p300, CBP, Tip60, and gelsolin are highly expressed in endocrine therapy-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Coactivators SRC-1, TIF-2, RAC3, p300, CBP, Tip60, and gelsolin are highly expressed in endocrine therapy-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP436893.RAWdi9P0yAOG4mCI4LzroRZT7wuTRzrnAtHAE-IOquXrg130_assertion description "[Coactivators SRC-1, TIF-2, RAC3, p300, CBP, Tip60, and gelsolin are highly expressed in endocrine therapy-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436893.RAWdi9P0yAOG4mCI4LzroRZT7wuTRzrnAtHAE-IOquXrg130_provenance.
- NP498702.RAXBSkL0SdNtRE1Cw_bo9ii0EIlWLkxXAHmkmLU9rKMtI130_assertion description "[Coactivators SRC-1, TIF-2, RAC3, p300, CBP, Tip60, and gelsolin are highly expressed in endocrine therapy-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498702.RAXBSkL0SdNtRE1Cw_bo9ii0EIlWLkxXAHmkmLU9rKMtI130_provenance.
- NP498701.RAn79BIhFFlvlWNi88jKHUW_AI_x5aeiQKs-J0RqIKekY130_assertion description "[Coactivators SRC-1, TIF-2, RAC3, p300, CBP, Tip60, and gelsolin are highly expressed in endocrine therapy-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498701.RAn79BIhFFlvlWNi88jKHUW_AI_x5aeiQKs-J0RqIKekY130_provenance.
- NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_assertion description "[Coactivators SRC-1, TIF-2, RAC3, p300, CBP, Tip60, and gelsolin are highly expressed in endocrine therapy-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_provenance.